NCT00002982View on ClinicalTrials.gov

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 1997

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

carmustine

DRUG

cytarabine

DRUG

etoposide

DRUG

ifosfamide

DRUG

melphalan

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002982 - Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter